Additionally, flavonoids like silibinin selectively inhibit WNT signaling in cancer cells harboring specific mutations (e.g., mutant APC), highlighting their potential for targeted therapeutic strategies (Kaur et al., 2010). This evidence concerns the gene APC and cancer.